Kenvue Inc.

Equities

KVUE

US49177J1025

Personal Products

Market Closed - Nyse 04:00:02 2024-04-22 pm EDT 5-day change 1st Jan Change
19.58 USD 0.00% Intraday chart for Kenvue Inc. +2.35% -9.06%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Contaminated cough syrup in Africa no longer available - WHO RE
WHO Likely to Issue Broader Alert on Cough Syrup Following Recall in Nigeria MT
WHO Likely to Issue Wider Warning About J&J Cough Syrup Contamination, Reuters Reports DJ
WHO says wider alert on contaminated J&J cough syrup 'likely' RE
MEDIA-Zimbabwe recalls tainted J&J's cough syrup sold in six African nations- Bloomberg News RE
Rwanda joins other African countries in recalling J&J children's cough syrup RE
Kenya recalls J&J children's cough syrup over suspected toxicity RE
Kenya recalls J&J children's cough syrup over suspected toxicity RE
Will there be any Fed rate cuts this year? Our Logo
Bernstein Starts Kenvue With Underperform Rating, $18 Price Target MT
ANALYST RECOMMENDATIONS : Chipotle, Micron, Mastercard, Snowflake, Airbnb... Our Logo
Nigeria recalls J&J children's cough syrup over toxic substance RE
Kenvue's Neutrogena to Shut Down Los Angeles Office MT
News Highlights : Top Company News of the Day - Tuesday at 3 AM ET DJ
News Highlights : Top Company News of the Day - Tuesday at 1 AM ET DJ
News Highlights : Top Company News of the Day - Monday at 11 PM ET DJ
News Highlights : Top Company News of the Day - Monday at 9 PM ET DJ
News Highlights : Top Company News of the Day - Monday at 5 PM ET DJ
News Highlights : Top Company News of the Day - Monday at 7 PM ET DJ
News Highlights : Top Company News of the Day - Monday at 3 PM ET DJ
News Highlights : Top Company News of the Day - Monday at 1 PM ET DJ
William Blair Initiates Kenvue With Market Perform Rating MT
Investors hope GE spinoff will defy poor track record of breakups RE
Goldman Sachs Downgrades Kenvue to Neutral From Buy, Cuts Price Target to $20 From $26 MT
North American Morning Briefing : Stock Futures -2- DJ
Chart Kenvue Inc.
More charts
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: - health products: for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - body care products: hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.); - other: notably oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.). Product marketing is assured through direct sales, distributors and the Internet.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
19.58 USD
Average target price
22.44 USD
Spread / Average Target
+14.59%
Consensus
  1. Stock Market
  2. Equities
  3. KVUE Stock
  4. News Kenvue Inc.
  5. Sector Update: Health Care Stocks Dropping in Afternoon Trade